88IV - Public company info - Consun Pharmaceutical Group Ltd.

Input the stock code or the company name

Consun Pharmaceutical Group Ltd., 01681.HK - Cash Flow	2020-12	2019-12	2018-12	2017-12	2016-12	2015-12	2014-12	2013-12	2012-12
Net Cash Flow from Operating Activities	982,376	543,652	874,845	345,720	511,318	246,818	337,346	207,559	180,605
Net Cash Flow from Return on Investments & Servicing of Finance	-125,004	-243,679	-89,775	-204,540	-93,033	-14,592	-14,407	-178,677	1,428
Interest Received	27,888	16,751	11,266	3,469	22,988	13,849	23,593	3,230	2,340
Interest Paid	-21,401	-24,720	-22,526	-24,020	-1,509	-441	0	0	0
Dividend Received	0	0	0	0	0	0	0	0	0
Dividend Paid	-131,491	-235,710	-78,515	-183,989	-114,512	-28,000	-38,000	-181,907	-912
Others	0	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	-115,318	-160,337	-120,635	-93,597	-62,141	-62,775	-42,625	-43,949	-51,773
Net Cash Flow from Investing Activities	-53,591	-126,883	-192,070	-63,518	68,900	-469,655	-271,872	13,048	-113,804
Additions to Fixed Assets	-48,703	-179,746	-193,348	-64,446	-65,428	-17,281	-20,972	-64,085	-37,334
Disposal of Fixed Assets	112	1,043	1,278	928	293	526	0	663	0
Increase in Investments	0	0	0	0	134,035	-641,342	-250,900	0	0
Decrease in Investments	0	0	0	0	0	250,900	0	0	0
Net Cash Flow with Related Parties	0	0	0	2,838	-71,188	0	0	0	0
Others	-5,000	51,820	0	-2,838	71,188	-62,458	0	76,470	-76,470
Net Cash Flow before Financing Activities	688,463	12,753	472,365	-15,935	425,044	-300,204	8,442	-2,019	16,456
Net Cash Flow from Financing Activities	-126,912	103,768	-191,384	336,134	-242,320	-53,478	-66,799	822,290	428
New Loans	263,757	607,458	0	653,707	0	95,000	20,000	37,000	0
Loans Repayment	-237,924	-459,969	-197,008	-59,066	-90,000	-95,000	-20,000	-37,000	-13,600
Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0	0
Equity Financing	0	2,491	5,624	244,371	0	0	0	852,925	14,028
Net Cash Flow with Related Parties	0	0	0	2,838	-71,188	0	0	0	0
Others	-152,745	-46,212	0	-505,716	-81,132	-53,478	-66,799	-30,635	0
Increase(Decrease) in Cash & Cash Equivalents	561,551	116,521	280,981	320,199	182,724	-353,682	-58,357	820,271	16,884
Cash & Cash Equivalents at Beginning of Year	1,383,232	1,269,746	989,565	672,711	489,987	843,669	902,026	81,755	64,871
Net Cash Flow due to Change in Exchange Rate/Others	-4,510	-3,035	-800	-3,345	0	0	0	0	0
Cash & Cash Equivalents at End of Year	1,940,273	1,383,232	1,269,746	989,565	672,711	489,987	843,669	902,026	81,755
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	1	1	1	1	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Consun Pharmaceutical Group Ltd. , 01681.HK